Financhill
Sell
27

MRNA Quote, Financials, Valuation and Earnings

Last price:
$24.26
Seasonality move :
24.17%
Day range:
$24.22 - $25.32
52-week range:
$23.15 - $170.47
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.01x
P/B ratio:
0.93x
Volume:
7.1M
Avg. volume:
9.9M
1-year change:
-80.23%
Market cap:
$9.4B
Revenue:
$3.2B
EPS (TTM):
-$8.73

Earnings Data

Next earnings date for MRNA
Aug 01
2025
Most recent earnings per share
-$2.52
Beat by $0.59
(May 1/2025)
Consensus Estimate
-$3.11
(May 1/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

MRNA Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/01/2025 Q2 $110.8M -- -- -$2.96 --
05/01/2025 Q1 $115.3M $107M -$2.52 -$3.11 $0.59
02/14/2025 Q4 $941.1M $956M -$2.91 -$2.73 -$0.18
11/07/2024 Q3 $1.2B $1.9B $0.03 -$1.94 $1.97
08/01/2024 Q2 $134.9M $221M -$3.33 -$3.36 $0.03
05/02/2024 Q1 $125.3M $167M -$3.07 -$3.55 $0.48
02/22/2024 Q4 $2.5B $2.8B $0.55 -$0.99 $1.54
11/02/2023 Q3 -- -- -$9.53 -$2.05 -$7.48
06/30/2023 Q2 -- -- -$3.62 -$4.12 $0.50
03/31/2023 Q1 -- -- $0.19 -$1.73 $1.92
12/31/2022 Q4 -- -- $3.61 $4.60 -$0.99
09/30/2022 Q3 -- -- $2.53 $3.11 -$0.58
06/30/2022 Q2 -- -- $5.24 $4.49 $0.75
03/31/2022 Q1 -- -- $8.58 -- --
12/31/2021 Q4 -- -- $11.29 -- --
09/30/2021 Q3 -- -- $7.70 -- --
06/30/2021 Q2 -- -- $6.46 -- --
03/31/2021 Q1 -- -- $2.84 -- --
12/31/2020 Q4 -- -- -$0.69 -- --
09/30/2020 Q3 -- -- -$0.59 -- --
06/30/2020 Q2 -- -- -$0.31 -- --
03/31/2020 Q1 -- -- -$0.35 -- --
12/31/2019 Q4 -- -- -$0.37 -- --
09/30/2019 Q3 -- -- -$0.37 -- --
06/30/2019 Q2 -- -- -$0.41 -- --
03/31/2019 Q1 -- -- -$0.40 -- --
12/31/2018 Q4 -- -- -$0.43 -- --
09/30/2018 Q3 -- -- -$0.27 -- --
06/30/2018 Q2 -- -- -$0.24 -- --
03/31/2018 Q1 -- -- -$0.19 -- --
12/31/2017 Q4 -- -- -$0.10 -- --

Moderna Earnings Questions

  • How Much did Moderna Generate in Revenue Last Quarter?

    Moderna reported $107M worth of top line sales in its most recent quarter.

  • Did Moderna Beat Earnings Last Quarter?

    Moderna announced earnings per share of -$2.52 which represents a beat of analyst forecast a -$3.11 per share.

  • Is Moderna Profitable?

    Moderna reported $17M that represents $0.04 per share over the last quarter.

  • What is the Analyst Consensus for Moderna EPS Next Year?

    Moderna's earnings are forecast to decrease from -$9.28 per share to -$9.03 per share next year representing a decrease of -8.28%.

  • When is Moderna's Earnings Date?

    Moderna's next earnings date is August 1, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Spotify a Millionaire-Maker Stock?
Is Spotify a Millionaire-Maker Stock?

Spotify (NYSE:SPOT) may seem like an expensive proposition trading closer…

What Is a Millionaire-Maker Stock?
What Is a Millionaire-Maker Stock?

From time to time, investors will run across the term…

5 Investors to Follow Other Than Warren Buffett
5 Investors to Follow Other Than Warren Buffett

There is no doubt that Warren Buffett is one of…

Stock Ideas

Buy
68
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy
61
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 40x

Alerts

Buy
60
RGC alert for May 10

Regencell Bioscience Holdings [RGC] is up 79.25% over the past day.

Buy
97
NGVC alert for May 10

Natural Grocers by Vitamin Cottage [NGVC] is up 30.26% over the past day.

Sell
38
ONTO alert for May 10

Onto Innovation [ONTO] is down 30.17% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock